Commentary on 'Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis' by Preiss et al

Diab Vasc Dis Res. 2012 Jan;9(1):78. doi: 10.1177/1479164111430337.

Author

Nikolaus Marx¹

Affiliation

¹ RWTH Aachen, Pauwelsstrasse 30, Aachen 52074, Germany. nmarx@ukaachen.de

PMID: 22158545
DOI: 10.1177/1479164111430337

No abstract available

MeSH terms

Diabetes Mellitus / chemically induced*
Diabetes Mellitus / epidemiology
Dose-Response Relationship, Drug
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Meta-Analysis as Topic
Odds Ratio
Risk Assessment
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors